Literature DB >> 27056579

Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995.

Yoko Murphy1, Emily Wilson2, Elliot M Goldner2, Benedikt Fischer3,4,5.   

Abstract

Benzodiazepines are commonly prescribed psycho-pharmaceuticals (e.g., for anxiety, tension, and insomnia); they are generally considered safe but have potential adverse effects. Benzodiazepine use in Canada versus internationally is comparably high, yet no recent comprehensive review of use, misuse, or related (e.g., morbidity, mortality) harm at the population level exists; the present review aimed to fill this gap. We searched four key scientific literature databases (Medline, CINAHL, EBM Reviews, and Web of Science) with relevant search terms, and collected relevant "gray literature" (e.g., survey, monitoring, government reports) data published in 1995-2015. Two reviewers conducted data screening and extraction; results were categorized and narratively summarized by key sub-topics. Levels of benzodiazepine use in the general population have been relatively stable in recent years; medical use is generally highest among older adults. Rates of non-medical use are fairly low in general but higher in marginalized (e.g., street drug use) populations; high and/or inappropriate prescribing appears common in older adults. Benzodiazepines are associated with various morbidity outcomes (e.g., accidents/injuries, cognitive decline, sleep disturbances, or psychiatric issues), again commonly observed in older adults; moreover, benzodiazepines are identified as a contributing factor in suicides and poisoning deaths. Overall there is a substantial benzodiazepine-related health problem burden-although lower than that for other psycho-medications (e.g., opioids)-in Canada, mainly as a result of overuse and/or morbidity. National benzodiazepine prescription guidelines are lacking, and few evaluated interventions to reduce benzodiazepine-related problems exist. There is a clear need for reducing inappropriate benzodiazepine use and related harm in Canada through improved evidence-based practice as well as monitoring and control.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27056579     DOI: 10.1007/s40261-016-0397-8

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  101 in total

Review 1.  Clinical practice guidelines. Management of anxiety disorders.

Authors: 
Journal:  Can J Psychiatry       Date:  2006-07       Impact factor: 4.356

2.  Toxicological findings in fatal motor vehicle collisions in ontario, Canada: a one-year study.

Authors:  Karen L Woodall; Betty L C Chow; Albert Lauwers; Dan Cass
Journal:  J Forensic Sci       Date:  2015-02-18       Impact factor: 1.832

3.  Mental health for older adults and benzodiazpine use.

Authors:  Philippe Voyer; Philippe Cappeliez; Guilhéme Pérodeau; Michel Préville
Journal:  J Community Health Nurs       Date:  2005       Impact factor: 0.974

4.  Urine drug testing for social service agencies in Nova Scotia, Canada.

Authors:  A D Fraser
Journal:  J Forensic Sci       Date:  1998-01       Impact factor: 1.832

5.  Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users.

Authors:  Thomas Kerr; Nadia Fairbairn; Mark Tyndall; David Marsh; Kathy Li; Julio Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2006-09-07       Impact factor: 4.492

6.  Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use.

Authors:  Colleen M Cunningham; Gillian E Hanley; Steve Morgan
Journal:  Health Policy       Date:  2010-04-21       Impact factor: 2.980

7.  Inappropriate prescribing before and after nursing home admission.

Authors:  Irfan A Dhalla; Geoffrey M Anderson; Muhammad M Mamdani; Susan E Bronskill; Kathy Sykora; Paula A Rochon
Journal:  J Am Geriatr Soc       Date:  2002-06       Impact factor: 5.562

8.  Pain, medication, and injury in older farmers.

Authors:  D C Voaklander; K D Kelly; B H Rowe; D P Schopflocher; L Svenson; N Yiannakoulias; W Pickett
Journal:  Am J Ind Med       Date:  2006-05       Impact factor: 2.214

Review 9.  Receptors for the age of anxiety: pharmacology of the benzodiazepines.

Authors:  J F Tallman; S M Paul; P Skolnick; D W Gallager
Journal:  Science       Date:  1980-01-18       Impact factor: 47.728

10.  Association between risk factors for injurious falls and new benzodiazepine prescribing in elderly persons.

Authors:  Gillian Bartlett; Michal Abrahamowicz; Roland Grad; Marie-Pierre Sylvestre; Robyn Tamblyn
Journal:  BMC Fam Pract       Date:  2009-01-06       Impact factor: 2.497

View more
  11 in total

1.  Predictors of self-medication in Serbian adult population: cross-sectional study.

Authors:  Katica Tripković; Andjelija Nešković; Janko Janković; Marina Odalović
Journal:  Int J Clin Pharm       Date:  2018-03-30

2.  Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments.

Authors:  Sebastian T Tong; Kathryn M Polak; Michael F Weaver; Gabriela C Villalobos; Wally R Smith; Dace S Svikis
Journal:  J Am Board Fam Med       Date:  2019 Mar-Apr       Impact factor: 2.657

3.  Factors associated with sedative use and misuse among heroin users.

Authors:  Tabitha E H Moses; Leslie H Lundahl; Mark K Greenwald
Journal:  Drug Alcohol Depend       Date:  2018-02-02       Impact factor: 4.492

4.  Patients reasons for obtaining psychotropic medications without a prescription at retail pharmacies in Central Saudi Arabia.

Authors:  Fahad D Alosaimi; Fay S Alruwais; Fadah A Alanazi; Ghaida A Alabidi; Nadia A Aljomah; Nuha S Alsalameh
Journal:  Neurosciences (Riyadh)       Date:  2016-10       Impact factor: 0.906

5.  Beyond Prescriptions Monitoring Programs: The Importance of Having the Conversation about Benzodiazepine Use.

Authors:  Erin Oldenhof; Jane Anderson-Wurf; Kate Hall; Petra K Staiger
Journal:  J Clin Med       Date:  2019-12-04       Impact factor: 4.241

6.  The Association between General Anesthesia and New Postoperative Uses of Sedative-Hypnotics: A Nationwide Matched Cohort Study.

Authors:  Chen-Yu Tai; Hsin-Yi Liu; Juan P Cata; Ying-Xiu Dai; Mu-Hong Chen; Jui-Tai Chen; Tzeng-Ji Chen; Hsiang-Ling Wu; Yih-Giun Cherng; Chun-Cheng Li; Chien-Wun Wang; Ying-Hsuan Tai
Journal:  J Clin Med       Date:  2022-06-11       Impact factor: 4.964

Review 7.  Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.

Authors:  Amber N Edinoff; Catherine A Nix; Amira S Odisho; Caroline P Babin; Alyssa G Derouen; Salim C Lutfallah; Elyse M Cornett; Kevin S Murnane; Adam M Kaye; Alan D Kaye
Journal:  Neurol Int       Date:  2022-08-22

8.  Prescription of potentially inappropriate medications among older people with intellectual disability: a register study.

Authors:  Anna Axmon; Magnus Sandberg; Gerd Ahlström; Patrik Midlöv
Journal:  BMC Pharmacol Toxicol       Date:  2017-10-25       Impact factor: 2.483

9.  Patterns of benzodiazepines use in primary care adults with anxiety disorders.

Authors:  Marie-Michèle Tanguay Bernard; Mireille Luc; Jean-Daniel Carrier; Louise Fournier; Arnaud Duhoux; Elodie Côté; Olivier Lessard; Catherine Gibeault; Christian Bocti; Pasquale Roberge
Journal:  Heliyon       Date:  2018-07-09

10.  Gender Differences in Predictors of Self-Medication with Tranquillizers and Sleeping Pills: Results of the Population-Based Study in Serbia.

Authors:  Katica Tripković; Milena Šantrić Milićević; Marina Odalović
Journal:  Zdr Varst       Date:  2019-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.